John Ryan, a recognised leader in public health and safety approaches to drugs, is the CEO of Penington Institute.
Penington Institute is the convenor of International Overdose Awareness Day, a burgeoning global event that was observed in 38 countries at approximately 1000 registered events in 2018.
Penington Institute has also been instrumental in the Australian adoption of community-based naloxone programs and it publishes the Australian Annual Overdose Report.
John actively works to promote evidence-based responses to drug use in the community, media and government, and he is currently one of the three members of the Victorian Government-appointed Medically Supervised Injecting Facility Review Panel.
John, a former needle and syringe program worker, university researcher and government policy worker, is also President of London-based Harm Reduction International (HRI). HRI is a leading non-governmental organisation focused on reducing the negative health, social and human rights impacts of drug use and drug policy.
John holds a Bachelor of Arts and a Bachelor of Laws from Monash University. In 2012, he received a Churchill Fellowship to study ways to enhance public health approaches to drug policy.